Repligen News and Activities

Presence

Repligen makes bioprocessing tools and materials for drug manufacturing. Its products include filtration systems, chromatography components, process analytics, and protein solutions for biopharma companies and contract manufacturers.

Repligen products and services overview:

Filtration systems
Chromatography products
Process analytics
Protein solutions
Fluid management
Single use systems

Revenue: ~$630 million

Employees: 1,800

Headquarters: Waltham, United States (USA)

Repligen is one of the...

Repligen is a company listed under the stock ticker RGEN (US).

Repligen has a direct presence in 2 countries.

Executives

View the org chart displaying its 37 main executives

Most searched biographies at Repligen

Popular executive movements at Repligen

Kola Otitoju, Senior Vice President of Strategy and Business Development & Global Head of Bioprocess Analytics, has left the company (posted on April 23 2026).
Martin Madaus who is Director, will be promoted to Chairman of the Board on Mar. 13, 2026 (posted on January 7 2026).
Tony Hunt, Executive Chairman of the Board, will retire on Mar. 13, 2026 (posted on January 7 2026).

Click here to view some more movements at Repligen

Create your alert
to follow the executive moves at Repligen.